NC-stat DPNCheck can improve the effectiveness of neuropathy detection programs and is ideal for:
- Health Risk Assessment Service Providers for In-home Use
- Clinic Based Health Risk Assessments
Why Use Nerve Conduction to Detect Diabetic Peripheral Neuropathy (DPN)?
The expected rate of neuropathy approaches 50%1 but is often missed with traditional detection methods such as monofilament testing2
- Traditional detection tools (monofilament or tuning fork) detect only late stage neuropathy and have low sensitivity
- Due to the subjective nature of these tests they are usually performed by physicians not staff
- Compliance rates for the performance of these tests are typically poor
- Sural nerve conduction detects DPN with high diagnostic sensitivity at all stages of severity
Benefits of Improved DPN Detection in a Managed Care Organization:
- Accurately risk assess diabetes patients
- Early diagnosis of DPN presents opportunities to intervene and reduce costs
- Identify those patients with neuropathy that are at highest risk for neuropathy related complications such as foot ulcers, neuropathic pain, and falls - DPN related ulcers and amputations have 5 year mortality rates comparable to colon cancer and worse than other common cancers, click here to view mortality data
- Efficient and cost effective testing
DPNCheck Clinical Validation
The NC-stat DPNCheck has been clinically validated in numerous peer-reviewed journal publications and clinical conference presentations. Click here to view the complete list.